SLC16A3 and hepatocellular carcinoma: On the other hand, recent studies indicate that SLC16A3 also participates in regulating ferroptosis: inhibiting its expression can reduce extracellular lactic acid accumulation, ameliorate the hypoxic tumor microenvironment, and induce ferroptosis in HCC by blocking ERK pathway activation [46].